Background Actinobacteria is as a group of advanced filamentous bacteria. Rare
Actinobacteria are of special interest as they are rarely isolated from the environments. They …

The ability to produce plethora of secondary metabolites and enzymes for pharmaceutical,
agricultural and biotechnological applications make actinobacteria one of the most explored …

The presence of secondary metabolite biosynthetic gene clusters (BGCs) makes
actinobacteria well-known producers of diverse metabolites. These ubiquitous microbes are …

For decades, scientists have conducted bioprospecting on Actinobacteria for the discovery
of novel genera producing bioactive metabolites (Atalan et al., 2000; Bull et al., 2000; …

Actinobacteria are well-recognised biosynthetic factories that produce an extensive
spectrum of secondary metabolites. Recent genomic insights seem to impact the exploitation …

Actinobacteria constitute a highly diverse bacterial phylum with an unrivalled metabolic
versatility. They produce most of the clinically used antibiotics and a plethora of other natural …

Actinomycetes have been proven to be an excellent source of secondary metabolites for
more than half a century. Exhibiting various bioactivities, they provide valuable approved …

The current review aims to summarise the biodiversity and biosynthesis of novel secondary
metabolites compounds, of the phylum Actinobacteria and the diverse range of secondary …

Actinobacteria characterize the most important part of the microbial community as they are
the sources of novel bioactive compounds. This phylum has the capacity to grow in extreme …

Background Antibiotic resistance is on the rise, and new antibiotic research has slowed in
recent years, necessitating the discovery of possibly novel microbial resources capable of …